Anova Recognizes 1,500 Prostate Cancer Patients Treated with Accuray CyberKnife

Anova Recognizes 1,500 Prostate Cancer Patients Treated with Accuray CyberKnife
Anova Cancer Care, in Colorado, recently announced that it has treated 1,500 prostate cancer patients using the CyberKnife System, a radiation therapy device designed to deliver stereotactic body radiation therapy (SBRT), an advanced form of high-dose radiation, directly to the tumor to minimize damage to nearby healthy tissue. "We use the CyberKnife for prostate cancer because it offers distinct advantages when treating this disease; most notably it's the only system available with the ability to track movement of the pr
Subscribe or to access all post and page content.

One comment

  1. Joel Belsky says:

    I just had my second PSA test since Cyberknife. Prior to radiation PSA was 5.1 and Gleason was 3+3. Two cores of 20 showed cancer. With that 4 months post radiation PSA dropped to 1.95. However 8 months post Cyberknife PSA was 2.03. I realize not a huge jump, but I expected it to be 1.0 – 1.3.

Leave a Comment

Your email address will not be published. Required fields are marked *